Tirzepatide
Tirzepatide
(10 mg)
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research contexts, particularly in relation to insulin secretion dynamics and energy homeostasis.
$90.00
Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist representing the next generation of incretin-based research compounds. By engaging two metabolic pathways simultaneously, it has drawn significant attention in studies examining body composition, insulin sensitivity, and lipid profiles. Its unique dual-agonist mechanism produces effects in research models that single-pathway peptides do not replicate. Each vial is lyophilized for maximum shelf stability and tested for purity. For research and laboratory use only.
